Iovance Biotherapeutics
IOVA
#3883
Rank
ยฃ2.44 B
Marketcap
ยฃ5.27
Share price
-5.61%
Change (1 day)
208.32%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2026 (TTM): -ยฃ0.23 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2025 the company made an earning of -ยฃ0.31 Billion a decrease over its 2024 earnings that were of -ยฃ0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.23 Billion-27.17%
2025 -ยฃ0.31 Billion0.74%
2024 -ยฃ0.31 Billion-14.17%
2023 -ยฃ0.36 Billion15.46%
2022 -ยฃ0.31 Billion16.39%
2021 -ยฃ0.27 Billion30.83%
2020 -ยฃ0.21 Billion26.62%
2019 -ยฃ0.16 Billion61.29%
2018 -ยฃ98.05 Million38.09%
2017 -ยฃ71 Million73.16%
2016 -ยฃ41.01 Million92.7%
2015 -ยฃ21.28 Million131.17%
2014 -ยฃ9.21 Million-51.71%
2013 -ยฃ19.07 Million6291.81%
2012 -ยฃ0.3 Million
2008 -ยฃ0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.66 Million-99.27% Bahamas
NRC Health
NRC
ยฃ11.3 M-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA